Tompkins Financial Corp Increases Stake in Danaher Co. (NYSE:DHR)

Tompkins Financial Corp boosted its position in Danaher Co. (NYSE:DHR) by 1.8% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 35,406 shares of the conglomerate’s stock after acquiring an additional 626 shares during the period. Tompkins Financial Corp’s holdings in Danaher were worth $7,258,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in DHR. Vanguard Group Inc. lifted its stake in shares of Danaher by 0.5% during the 4th quarter. Vanguard Group Inc. now owns 59,750,122 shares of the conglomerate’s stock valued at $13,715,641,000 after buying an additional 315,912 shares in the last quarter. Geode Capital Management LLC grew its stake in Danaher by 2.4% in the 4th quarter. Geode Capital Management LLC now owns 13,358,206 shares of the conglomerate’s stock valued at $3,056,996,000 after buying an additional 315,446 shares in the last quarter. Norges Bank bought a new stake in Danaher during the 4th quarter valued at $2,130,740,000. Bank of New York Mellon Corp lifted its position in shares of Danaher by 5.4% during the fourth quarter. Bank of New York Mellon Corp now owns 8,589,019 shares of the conglomerate’s stock worth $1,971,609,000 after acquiring an additional 441,012 shares in the last quarter. Finally, Northern Trust Corp boosted its holdings in shares of Danaher by 14.3% in the fourth quarter. Northern Trust Corp now owns 7,934,991 shares of the conglomerate’s stock worth $1,821,477,000 after acquiring an additional 992,594 shares during the period. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Trading Up 0.7%

DHR stock opened at $190.38 on Friday. The company has a market capitalization of $136.25 billion, a PE ratio of 36.06, a price-to-earnings-growth ratio of 2.66 and a beta of 0.80. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a one year low of $171.00 and a one year high of $281.70. The company’s 50 day moving average price is $193.18 and its two-hundred day moving average price is $214.13.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.26. The company had revenue of $5.74 billion for the quarter, compared to analysts’ expectations of $5.58 billion. Danaher had a net margin of 16.33% and a return on equity of 10.82%. As a group, analysts predict that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.67%. Danaher’s dividend payout ratio (DPR) is presently 24.85%.

Wall Street Analyst Weigh In

DHR has been the topic of a number of analyst reports. Royal Bank of Canada reiterated an “outperform” rating and set a $250.00 price objective on shares of Danaher in a research note on Wednesday, April 23rd. Jefferies Financial Group reduced their target price on Danaher from $260.00 to $230.00 and set a “buy” rating for the company in a report on Tuesday, April 22nd. Guggenheim restated a “buy” rating and issued a $250.00 price objective on shares of Danaher in a research report on Wednesday, April 23rd. Robert W. Baird lowered their price objective on Danaher from $231.00 to $225.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 23rd. Finally, The Goldman Sachs Group cut their price objective on Danaher from $260.00 to $240.00 and set a “neutral” rating for the company in a report on Wednesday, April 23rd. Five research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat.com, Danaher has an average rating of “Moderate Buy” and a consensus price target of $263.24.

Insider Activity at Danaher

In other Danaher news, Chairman Steven M. Rales sold 1,250,000 shares of the firm’s stock in a transaction on Monday, May 12th. The shares were sold at an average price of $196.74, for a total value of $245,925,000.00. Following the sale, the chairman now owns 3,105,808 shares of the company’s stock, valued at $611,036,665.92. This trade represents a 28.70% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Christopher Paul Riley sold 15,805 shares of the business’s stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the transaction, the executive vice president now owns 15,179 shares in the company, valued at $3,005,442. The trade was a 51.01% decrease in their position. The disclosure for this sale can be found here. 11.20% of the stock is currently owned by company insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.